THERAPEUTIC CONSIDERATIONS IN THE DISEASES OF PORPHYRIN METABOLISM.
D000227:Adenine Nucleotides; D000324:Adrenocorticotropic Hormone; D018926:Anti-Allergic Agents; D001463:Barbiturates / Q000633:toxicity*; D002614:Chelating Agents; D002746:Chlorpromazine; D003933:Diagnosis; D005260:Female; D001556:Hexachlorocyclohexane; D006634:Histamine H1 Antagonists; D007239:Infections; D009461:Neurologic Manifestations; D026741:Physical Therapy Modalities; D011164:Porphyrias; D011166:Porphyrins; D011175:Positive-Pressure Respiration; D011247:Pregnancy; D011248:Pregnancy Complications; D011395:Promazine; D013156:Splenectomy; D013812:Therapeutics; D014025:Titanium; D014116:Toxicology; D015032:Zinc
D000227:Adenine Nucleotides; D018926:Anti-Allergic Agents; D001463:Barbiturates; D002614:Chelating Agents; D006634:Histamine H1 Antagonists; D011166:Porphyrins; D001556:Hexachlorocyclohexane; D000324:Adrenocorticotropic Hormone; D014025:Titanium; D015032:Zinc; D011395:Promazine; D002746:Chlorpromazine; C032232:barbituric acid
ADENINE NUCLEOTIDES; ANTIHISTAMINICS; BARBITURATE TOXICOLOGY; BENZENE HEXACHLORIDE; CHELATING AGENTS; CHLORPROMAZINE; CORTICOTROPIN; DIAGNOSIS; INFECTION; NEUROLOGIC MANIFESTATIONS; PHYSICAL THERAPY; PORPHYRIA; POSITIVE-PRESSURE RESPIRATION; PREGNANCY; PREGNANCY COMPLICATIONS; PROMAZINE; SPLENECTOMY; THERAPEUTICS; TITANIUM; TOXICOLOGIC REPORT; ZINC